Daljeet Kohli has raked in 200% gains from HSIL. The stock has corrected a bit and consolidated. Daljeet has now upgraded the stock from ‘hold’ to ‘buy’ and foreseen more gains from it
IndiaNivesh has issued an ‘Initiating Coverage’ report on Indoco Remedies claiming that the Company can deliver 46% CAGR earnings over FY14-17E and that there is huge upside from the stock
Today, there was great excitement in the air over the news that IndiaNivesh had sold off a huge chunk of Camson Bio-Tech, a stock earlier recommended by them. Have they lost confidence in the stock and does it spell doom for us?
ICICI-Direct’s Model Portfolio of large-cap and small-cap stocks has given impressive returns and heavily out-performed the Index. ICICI-Direct has updated the Model Portfolio by adding performers and removing non-performing stocks
Recent Comments